DAVID SNOW: Open Payments
NPI 1699228932 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 46 payments from 12 companies in 2025. Trend: 2023 $219 · 2024 $927 · 2025 $872
Food & beverage: $770Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $231 |
| E.R. Squibb & Sons, L.L.C. | 11 | $140 |
| Janssen Pharmaceuticals, Inc | 5 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $111 |
| Collegium Pharmaceutical, Inc. | 3 | $64 |
| ABBVIE INC. | 3 | $58 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Alkermes, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: COBENFY, INVEGA SUSTENNA, CAPLYTA, UZEDY, Jornay PM, VRAYLAR, AUSTEDO XR, LUMRYZ.
Industry payments across PA — which companies pay providers there.
